Dr Akheel Syed
Richard Bliss
Dr James Roberts
Dr Ujjal Mallick
Dr Sarah Johnson
et al. | Metachronous testicular teratoma, testicular seminoma and papillary thyroid carcinoma occurring in a single individual: a report of two unrelated cases | 2010 |
|
Professor Ghada Khattab
Dr James Roberts
| Working with Children | 2010 |
|
Dr James Roberts
| Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: A model update and multicentre validation with more than 1000 patients | 2007 |
|
Dr James Roberts
| Long- term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer | 2006 |
|
Dr James Roberts
| Chemotherapy for metastatic bladder cancer | 2005 |
|
Dr James Roberts
| Long-term-survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer | 2005 |
|
Dr James Roberts
| Modelling the expected increase in demand for particle radiotherapy: implications for the UK | 2005 |
|
Dr James Roberts
| Multidisciplinary teams improve the care of patients with cancer: the case against | 2005 |
|
Dr James Roberts
| Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: A report on medical research council trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328) | 2005 |
|
Dr James Roberts
| Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours | 2004 |
|
Mark Pearson
Dr Julian Thomas
Professor Martin Eccles
Dr James Roberts
| NICE clinical guidelines | 2004 |
|
Dr James Roberts
Albert Craig
| Radiotherapy in the UK: There are problems - What are the solutions? | 2004 |
|
Dr James Roberts
| The role of the nonsurgical oncologist in the management of advanced transitional cell cancer. Part I: locally advanced disease | 2004 |
|
Dr James Roberts
| The role of the nonsurgical oncologist in the management of advanced transitional cell cancer. Part II: metastatic disease | 2004 |
|
Dr James Roberts
| External validity of a prediction rule for residual mass histology in testicular cancer: an evaluation for good prognosis patients | 2003 |
|
Dr James Roberts
| Quality of life in good prognosis patients with metastatic germ cell cancer: A prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20) | 2003 |
|
Dr James Roberts
| Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: A phase III study of the European Organisation for Research and Treatment of Cancer Genitourinary Group | 2003 |
|
Dr Khaver Qureshi
Thomas Griffiths
Dr Mary Robinson
Colin Marsh
Dr James Roberts
et al. | Combined p21WAF1/CIP1 and p53 overexpression predict improved survival in muscle-invasive bladder cancer treated by radical radiotherapy | 2001 |
|
Dr James Roberts
| Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: A randomized study of the European organization for research and treatment of cancer genitourinary tract cancer cooperative group and the medical research council | 2001 |
|
Joanne Cresswell
Dr James Roberts
Professor David Neal
| Urethral recurrence after radical radiotherapy for bladder cancer | 2001 |
|
Dr James Roberts
| A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma - Cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy | 2000 |
|
Dr James Roberts
| A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma | 2000 |
|
Dr James Roberts
| A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: Results of Medical Research Council Trial BA09 | 2000 |
|
Dr James Roberts
| Gemcitabine and cisplatin versus methotrexate vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large randomized, multinational, multicenter, phase III study | 2000 |
|
Dr James Roberts
| Alveolar rhabdomyosarcoma metastatic to the breast: Long-term survivor | 1999 |
|
Dr James Roberts
| Optimal planning target volume for stage I testicular seminoma: A medical research council randomized trial | 1999 |
|
Dr James Roberts
| Radical transurethral resection and chemotherapy in the treatment of muscle-invasive bladder cancer: a long-term follow-up | 1999 |
|
Dr Khaver Qureshi
Thomas Griffiths
Dr Mary Robinson
Dr James Roberts
Professor John Lunec
et al. | TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancer | 1999 |
|
